Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Immunodeficiency due to selective anti-polysaccharide antibody deficiency is characterized by normal immunoglobulin levels (including IgG sub-classes) but impaired polysaccharide responsiveness (IPR).
Biomarker and diagnostic research for immunodeficiency due to selective anti-polysaccharide antibody deficiency has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include biologic therapy. Research is primarily sponsored by academic and government institutions.
19 publications have been identified in PubMed for immunodeficiency due to selective anti-polysaccharide antibody deficiency. Research spans Review / Meta-Analysis (37%), Epidemiology / Natural History (21%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 7 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 6:08 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression | 4 | 21% |
Testing and diagnosis research | 3 | 16% |
Patient case studies | 2 | 11% |
Laboratory research | 2 | 11% |
Clinical study results | 1 | 5% |
Bista R (2026). [PMID: 42181854](https://pubmed.ncbi.nlm.nih.gov/42181854/). *Case Rep Pulmonol*. [Case Report / Case Series]
Song CH (2026). [PMID: 42154960](https://pubmed.ncbi.nlm.nih.gov/42154960/). *Acta Paediatr*. [Epidemiology / Natural History]
Ariue B (2026). [PMID: 41057108](https://pubmed.ncbi.nlm.nih.gov/41057108/). *Ann Allergy Asthma Immunol*. [Diagnostic / Biomarker]
Lewandrowski C (2026). [PMID: 41451820](https://pubmed.ncbi.nlm.nih.gov/41451820/). *Curr Opin Allergy Clin Immunol*. [Review / Meta-Analysis]
Petersen AG (2026). [PMID: 41087302](https://pubmed.ncbi.nlm.nih.gov/41087302/). *Clin Otolaryngol*. [Epidemiology / Natural History]
Suárez-Cuartín G (2025). [PMID: 41517428](https://pubmed.ncbi.nlm.nih.gov/41517428/). *J Clin Med*. [Review / Meta-Analysis]
Sgrulletti M (2025). [PMID: 41441703](https://pubmed.ncbi.nlm.nih.gov/41441703/). *Vaccines (Basel)*. [Review / Meta-Analysis]
Patel NC (2025). [PMID: 40085358](https://pubmed.ncbi.nlm.nih.gov/40085358/). *J Clin Immunol*. [Clinical Trial Publication]
Perrard N (2025). [PMID: 40097777](https://pubmed.ncbi.nlm.nih.gov/40097777/). *J Clin Immunol*. [Epidemiology / Natural History]
Rózsai B (2025). [PMID: 40656199](https://pubmed.ncbi.nlm.nih.gov/40656199/). *Front Pediatr*. [Basic Science / Preclinical]